176 related articles for article (PubMed ID: 21376373)
1. Investigation into the mechanism(s) of antithrombotic effects of carbon monoxide releasing molecule-3 (CORM-3).
Soni H; Jain M; Mehta AA
Thromb Res; 2011 Jun; 127(6):551-9. PubMed ID: 21376373
[TBL] [Abstract][Full Text] [Related]
2. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of relaxation by carbon monoxide-releasing molecule-2 in murine gastric fundus and jejunum.
De Backer O; Lefebvre RA
Eur J Pharmacol; 2007 Oct; 572(2-3):197-206. PubMed ID: 17610869
[TBL] [Abstract][Full Text] [Related]
5. Divergent mechanisms involved in CO and CORM-2 induced vasorelaxation.
Decaluwé K; Pauwels B; Verpoest S; Van de Voorde J
Eur J Pharmacol; 2012 Jan; 674(2-3):370-7. PubMed ID: 22108549
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effect with carbon monoxide releasing molecule-2 (CORM-2) in isolated perfused rat heart: Role of coronary endothelium and underlying mechanism.
Soni H; Patel P; Rath AC; Jain M; Mehta AA
Vascul Pharmacol; 2010; 53(1-2):68-76. PubMed ID: 20399902
[TBL] [Abstract][Full Text] [Related]
7. Carbon monoxide (CO)-releasing molecule-derived CO regulates tissue factor and plasminogen activator inhibitor type 1 in human endothelial cells.
Maruyama K; Morishita E; Yuno T; Sekiya A; Asakura H; Ohtake S; Yachie A
Thromb Res; 2012 Sep; 130(3):e188-93. PubMed ID: 22819264
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet and antithrombotic activities of salvianolic acid A.
Fan HY; Fu FH; Yang MY; Xu H; Zhang AH; Liu K
Thromb Res; 2010 Jul; 126(1):e17-22. PubMed ID: 20451955
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet aggregation by carbon monoxide-releasing molecules (CO-RMs): comparison with NO donors.
Chlopicki S; Lomnicka M; Fedorowicz A; Grochal E; Kramkowski K; Mogielnicki A; Buczko W; Motterlini R
Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):641-50. PubMed ID: 22362133
[TBL] [Abstract][Full Text] [Related]
10. Carbon monoxide from CORM-2 reduces HMGB1 release through regulation of IFN-β/JAK2/STAT-1/INOS/NO signaling but not COX-2 in TLR-activated macrophages.
Tsoyi K; Nizamutdinova IT; Jang HJ; Mun L; Kim HJ; Seo HG; Lee JH; Chang KC
Shock; 2010 Dec; 34(6):608-14. PubMed ID: 20442692
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of Bulnesia sarmienti aqueous extract on agonist-induced platelet activation and thrombus formation involves mitogen-activated protein kinases.
Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim KS; Hong JH; Kwak YS; Yun BS; Rhee MH
J Ethnopharmacol; 2010 Aug; 130(3):614-20. PubMed ID: 20558266
[TBL] [Abstract][Full Text] [Related]
12. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule.
Motterlini R; Sawle P; Hammad J; Bains S; Alberto R; Foresti R; Green CJ
FASEB J; 2005 Feb; 19(2):284-6. PubMed ID: 15556971
[TBL] [Abstract][Full Text] [Related]
13. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice.
Cepinskas G; Katada K; Bihari A; Potter RF
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G184-91. PubMed ID: 17991708
[TBL] [Abstract][Full Text] [Related]
14. Distinct Pharmacological Properties of Gaseous CO and CO-Releasing Molecule in Human Platelets.
Kaczara P; Przyborowski K; Mohaissen T; Chlopicki S
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808315
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.
Clark JE; Naughton P; Shurey S; Green CJ; Johnson TR; Mann BE; Foresti R; Motterlini R
Circ Res; 2003 Jul; 93(2):e2-8. PubMed ID: 12842916
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context.
Vadori M; Seveso M; Besenzon F; Bosio E; Tognato E; Fante F; Boldrin M; Gavasso S; Ravarotto L; Mann BE; Simioni P; Ancona E; Motterlini R; Cozzi E
Xenotransplantation; 2009; 16(2):99-114. PubMed ID: 19392725
[TBL] [Abstract][Full Text] [Related]
17. Carbon monoxide releasing molecule-2 inhibits pancreatic stellate cell proliferation by activating p38 mitogen-activated protein kinase/heme oxygenase-1 signaling.
Schwer CI; Mutschler M; Stoll P; Goebel U; Humar M; Hoetzel A; Schmidt R
Mol Pharmacol; 2010 Apr; 77(4):660-9. PubMed ID: 20053955
[TBL] [Abstract][Full Text] [Related]
18. [Study of exogenous carbon monoxide-releasing molecules 2 on endotoxin/lipopolysaccharide-induced abnormal activation of platelets of healthy human donors].
Liu D; Zhuang M; Zhang J; Chen J; Sun B
Zhonghua Shao Shang Za Zhi; 2015 Oct; 31(5):354-60. PubMed ID: 26714404
[TBL] [Abstract][Full Text] [Related]
19. Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule.
Tayem Y; Johnson TR; Mann BE; Green CJ; Motterlini R
Am J Physiol Renal Physiol; 2006 Apr; 290(4):F789-94. PubMed ID: 16291575
[TBL] [Abstract][Full Text] [Related]
20. Carbon monoxide induces cyclooxygenase-2 expression through MAPKs and PKG in phagocytes.
Lin LC; Ho FM; Yen SJ; Wu PY; Hung LF; Huang WJ; Liang YC
Int Immunopharmacol; 2010 Dec; 10(12):1520-5. PubMed ID: 20840837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
